期刊
CHEMICAL SCIENCE
卷 9, 期 12, 页码 3248-3253出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8sc00637g
关键词
-
资金
- National Key R&D Program of China [2017YFA0506800]
- National Natural Science Foundation of China [91753127, 31700123, 31741074]
- Shanghai Committee of Science and Technology, China [17ZR1449200]
- ShanghaiTech Startup Funding
- Young 1000 Talents Program
- CAS Strategic Priority Research Program [XDA16010108]
- CAS Hundred Talent Program
- China Postdoctoral Science Foundation [2017M620178]
Novel therapeutic means against Staphylococcus aureus infections are urgently needed due to the emergence of drug-resistant S. aureus. We report the development of a CRISPR RNA-guided cytidine deaminase (pnCasSA-BEC), enabling highly efficient gene inactivation and point mutations in S. aureus. We engineered a fusion of a Cas9 nickase (Cas9D10A) and a cytidine deaminase (APOBEC1) that can be guided to a target genomic locus for gene inactivation via generating a premature stop codon. The pnCasSA-BEC system nicks the non-edited strand of the genomic DNA, directly catalyzes the conversion of cytidine (C) to uridine (U), and relies on DNA replication to achieve C T (G A) conversion without using donor repair templates. The development of the base-editing system will dramatically accelerate drug-target exploration in S. aureus and provides critical insights into the development of base-editing tools in other microbes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据